Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline
about
Alpha(1A)-adrenoceptors mediate contractions to phenylephrine in rabbit penile arteriesPathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive ratsExistence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteriesFunctional characterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteriesDecreased blood pressure response in mice deficient of the alpha1b-adrenergic receptorAlpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-ARAntagonistic effects of selective alpha1-adrenoceptor antagonists MDL73005EF and tamsulosin and partial agonists clonidine and tizanidine in rat thoracic aorta and rabbit iliac artery.GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.Alpha(1D)-adrenergic receptor insensitivity is associated with alterations in its expression and distribution in cultured vascular myocytesAlpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypesalpha(1)-Adrenergic receptor subtype function in fetal and adult cerebral arteriesSubtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.Alpha-adrenergic approach in the medical management of benign prostatic hyperplasia.The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.Relationships between structure and vascular activity in a series of benzylisoquinolinesModulation of contraction by alpha(2A/D)-adrenoceptors in mouse aorta: evidence employing knockout technology.Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: role of neuropeptide Y.α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.Characterization of the alpha1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter.Smooth muscle alpha1D-adrenoceptors mediate phenylephrine-induced vasoconstriction and increases in endothelial cell Ca2+ in hamster cremaster arterioles.Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.Alterations of cardiac alpha 1-adrenoceptor subtypes in hypothyroid rats.Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth.Syntrophin isoforms play specific functional roles in the α1D-adrenergic receptor/DAPC signalosome.The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.Prostatic alpha 1-adrenoceptors and uroselectivity.The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade.Inhibition of the alpha(1D)-adrenergic receptor gene by RNA interference (RNAi) in rat vascular smooth muscle cells and its effects on other adrenergic receptors.Characterization of alpha 1 D-adrenoceptor subtype in rat myocardium, aorta and other tissues.
P2860
Q24564958-9F23DF12-B4A1-465C-9FE8-8F910B5F58A5Q28344888-21F97EC9-F6B6-4A34-A6E9-97013922A007Q28363092-9B55626E-6BD7-4407-B50E-C3DC5EF0808FQ28367878-FA5F6D00-7476-4405-8113-E2551D476E19Q28504510-49E7E8BF-B8A6-4B89-A771-CD906D7F8EACQ28510835-A91FDDDD-AC14-498C-989A-28AF3455F747Q32018992-72074B2F-63B4-4724-8B27-FE22F4DCC1D3Q33213253-61F3769A-FE3E-4984-911C-8B85C2D7406DQ33556427-01BDCBA2-6F4B-4EE4-813E-201374E7BF26Q33569502-8A0BD66D-0DF1-42C9-89CD-CF91575DB734Q33917207-BBD23D9A-826F-4C68-B961-B55B838A86DDQ34119559-6080243E-67BD-4560-AB1A-B6092BD8B17BQ34286429-657B8CD7-7C26-4B41-AAA1-9A8BA2719B3DQ34445169-C2D34BBB-29F9-4C70-96F9-C8FB647D088CQ34789836-DC2C7725-B606-414E-A3A2-AAF7FB847087Q35026723-D0443796-CEFD-48C3-BAE2-94AFB5530A37Q35044183-BBFC3C23-DE2D-4ADB-81BF-6369D4BD698BQ35044911-FD63CB7F-6387-4DD8-A44C-C4700B6C752CQ35049175-377C407F-65B3-49E9-A273-A6CFCA61BC43Q35092041-B697DABC-AC77-48B4-9642-4DB50A311C85Q35183611-D797FB95-383A-4896-8643-D6BBEBBE88A6Q35873551-38C9A358-8140-4A0D-A42A-BFB07A1E15F1Q35884569-D678FB58-0D58-437F-9F1E-3C576B17CA98Q36858292-1125AC39-DD27-44A0-B523-FD0CC4461387Q36964928-FEBFABEE-4BBE-4A0D-B05C-64E57F06506BQ37245331-2DADFB63-E955-4161-9483-21F1F0457C19Q37481315-2CAC6CD0-30B7-4154-BD9B-930CBBBB6559Q38344511-488BC0FD-BD2D-4A15-9EEE-5D9A8BEB8263Q38716504-2556D22B-6E07-4A66-ACE8-357685495F69Q39064824-6E2B124A-0CF5-4A5E-9CC8-B0308290CC45Q40303970-93BCA107-6676-4EB7-AFC4-DF3E90065AEEQ40499078-BE0A8D41-9F54-443C-8C43-C10F65318242Q41448071-312C6098-C22E-4900-9DDA-AAF741828786Q41780955-B28629CB-B8B7-46E9-BC6E-B1E2C7CC4127Q41808711-15A91899-0E01-4A34-A709-0AE0061FB278Q41842511-81E8723C-EBEE-42B3-B17A-B66F03F879AEQ42013671-B32A5E89-4284-421F-A2F1-2C62AFBC41C5Q42024159-45B2116B-FBF4-4FA2-B96E-2C38DE593490Q42053638-98E72ACD-5E0C-4756-B965-8C1E35931BA1Q42099177-4577F892-E70F-4D95-810A-EE9210A49AF7
P2860
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@en
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@nl
type
label
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@en
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@nl
prefLabel
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@en
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@nl
P2093
P2860
P1476
Characterization of an alpha 1 ...... of rat aorta to noradrenaline
@en
P2093
A M Naylor
D H Chalmers
P C Philpott
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15907.X
P407
P577
1995-07-01T00:00:00Z